Romanian Society of Pharmaceutical Sciences
 

« Back to Farmacia Journal 2/2021

DESIGN OF EXPERIMENTS APPROACH TO ASSESS THE IMPACT OF API PARTICLE SIZE ON FREEZE-DRIED BULKING AGENTS

ȘTEFANA SUCIU 1, SONIA IURIAN 1*, CĂTĂLINA BOGDAN 2, LUCIA RUS 3, ALIN SEBASTIAN PORAV 4, GHEORGHE BORODI 4, IOAN TOMUȚĂ 1

1.Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy “Iuliu Hațieganu”, Cluj-Napoca, Romania
2.Department of Dermatology and Cosmetics, Faculty of Pharmacy, University of Medicine and Pharmacy “Iuliu
Hațieganu”, Cluj-Napoca, Romania
3.Department of Drug Analysis, Faculty of Pharmacy, University of Medicine and Pharmacy “Iuliu Hațieganu”, Cluj-
Napoca, Romania
4.National Institute for Research and Development of Isotopic and Molecular Technologies, Cluj-Napoca, Romania

Download Full Article PDF

The current work aimed at the thorough characterization of freeze-dried bulking agent structures loaded with different particle sizes of active pharmaceutical ingredient (API). Using Design of Experiments, a D-Optimal screening design was conceived in order to evaluate the influence of the formulation factors on the features of the obtained structures. The selected formulation factors were API particle size (X1), the type of the bulking agent (X2) and the ratio of the bulking agent (X3). The disintegration time, the dissolution profile and the texture characteristics were studied. The particle size of the API (ibuprofen) influenced the dissolution and the highest dissolution ratios were obtained for trehalose. The texture characteristics of the structures were influenced by the type and the ratios of bulking agents, by increasing the ratio of the bulking agent, the measured parameters were improved. Maltodextrin conducted to robust structures for which, according to the XRPD results, the particles are to a certain degree in an amorphous state. The obtained results represent a contribution to the actual knowledge in this area that can be further used in development of lyophilized pharmaceutical forms.